Gene Therapy for β-Thalassemia

Download this slideset for an expert-curated overview of gene therapy for β-thalassemia, including the latest clinical data that may soon change practice.
Janet L. Kwiatkowski, MD, MSCE
Format: Microsoft PowerPoint (.ppt)
File Size: 796 KB
Released: December 6, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Celgene Corporation

Related Content

CME-certified Webcast of a CCO symposium at ASH 2019 featuring expert perspectives on the treatment of β-thalassemia, including insights on novel therapies.

Maria Domenica Cappellini, MD Janet L. Kwiatkowski, MD, MSCE Sujit Sheth, MD Physicians: maximum of 3.0 AMA PRA Category 1 Credits Released: January 15, 2020 Expiration: January 14, 2021

CCO faculty Maria Domenica Capellini, MD, provides insights on the use of luspatercept in the care of adult patients with transfusion-dependent β-thalassemia

Maria Domenica Cappellini, MD Released: January 13, 2020

Analysis of responders from BELIEVE study of luspatercept for transfusion-dependent β-thalassemia from ASH 2019 as reported by Clinical Care Options (CCO)

Released: December 17, 2019

Data from phase III CARDINAL trial of sutimlimab in patients with cold agglutinin disease presented at ASH 2019 reported by Clinical Care Options

Released: December 15, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?